I2SEED Training Program
An Immersive, Interdisciplinary Training Program for Workforce Development and Sustained Engagement in Entrepreneurship and Translational Research for Alzheimer’s Disease and Related Disorders
NEW 2023 PROGRAM OFFERING
Program Director: Nalaka Gooneratne MD, MSci
Co-Director: Katie Reuther, PhD, MBA
We are contacting you to let you know about an exciting new NIH-funded educational opportunity for your trainees. I2SEED a two-year entrepreneurship focused education program which provides training to help develop and commercialize diagnostic, supportive or therapeutic interventions for Alzheimer’s Disease and AD Related Disorders (ADRD). Trainees are expected to continue their full time position in their primary research/education program while they participate in I2SEED.
I2SEED offers coursework, experiential learning opportunities, sustained mentorship and will help trainees prepare a highly competitive NIH small-business grant in order to fund the next step of their product development pathway. The ultimate goal of this program is to maximize the likelihood that trainees will be able to obtain seed funding through a combination of SBIR/STTR grant(s) and investor funding so they can successfully transition to a funded career path that focuses on moving ADRD research from the bench to the bedside via a successful business plan.
We are currently accepting applications for the 2023 curriculum year. Trainees are expected to participate approximately 2-8 hours per week. This program is funded by the NIA and available at no cost to trainees and all activities include remote options to increase flexibility. Applicants do not need to have a fully formed concept and can be in the early stages of commercial exploration.
For more information, please reach out to Jennifer Morris, jennifer.morris3@pennmedicine.upenn.edu and visit the I2 SEED website.